Learning from the past to create the laboratory of the future With EUROLabOffice 4.0 the successful EUROIMMUN laboratory management software enters into its fourth generation and also heralds a new era of digital laboratory organisation. Whereas previously the advantage of middleware lay in the possibility of managing a paperless laboratory, today the aspects of complete […]
INOCHEM, S.A. DE C.V., a provider of highly specialized tests for accurate diagnostics in clinical laboratories and hospitals in the public and private segments in Mexico, is now part of EUROIMMUN. INOCHEM becomes the 16th affiliate of the Luebeck, Germany-based company. INOCHEM’s relationship with EUROIMMUN spans more than 14 years, initally as sub-distributor of another
Notification EUROIMMUN AG from Lübeck in Germany, a manufacturer of reagents and automated systems for medical laboratory diagnostics, has developed a PCR test for direct virus detection, in addition to the assays for the detection of antibodies against SARS-CoV-2 (ELISA). The new test is a real-time reverse transcriptase PCR used to detect the genetic material
Press release EUROIMMUN AG (Lübeck, Germany), a manufacturer of reagents and instruments for medical laboratory diagnostics, has developed serological tests for detection of antibodies against the novel coronavirus SARS-CoV-2. The two ELISAs enable detection of specific IgA and IgG against the virus in the blood of infected patients. In December 2019 the WHO in China
It all started at a market in Wuhan, China. Within a few weeks, a novel coronavirus, now called 2019-nCoV, spread to at least 15 regions or countries outside of the Chinese mainland. In December 2019, the WHO China Country Office was informed of cases of pneumonia of unknown aetiology (unknown cause) detected in Wuhan City,
